The PennZone

  • Home
  • Non-profit
  • Technology
  • Education
  • Construction
  • Business
  • Entertainment
  • Health
  • Software

Good news! The COVID-19 vaccine is coming to Whittier Health Network in Massachusetts
The PennZone/10102000

Trending...
  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan
  • Tennessee Laws Lead with Psychotropic Drug Testing in Mass Shooting Cases and Comprehensive Reporting: CCHR Urges Nationwide Adoption
  • Thou Shalt not Commit Adultery Lifetime Movie Discussion
Dr Paul Liguori receiving vaccine Philip Arcidi, Treasurer receiving vaccine Whittier Rehabilitation Hospital
The vaccine will be distributed at the Skilled Nursing Facilities, through a partnership with CVS, on a schedule beginning December 29th, and at our Transitional Care Units starting January 4th.

HAVERHILL, Mass. - PennZone -- Here's what you need to know.

At Whittier Health Network, we are dedicated to the well-being of our patients, residents, and staff, and we care for them just like family. That's why we are making sure the COVID-19 vaccine will be available at all of our facilities now that it is approved by the FDA and is currently being distributed.

We will hold a "vaccine clinic" throughout the Whittier Health Network beginning the last week of December. We urge our employees to sign up—for their safety and for the protection of their families and those they care for here at Whittier.

Our Medical staff will be taking the vaccine including our Medical Directors, Dr. Paul Liguori, MD, MRM at Whittier Rehabilitation Hospital Bradford and Dr. John V. Turchetta at Whittier Rehabilitation Hospital Westborough. Senior management at Whittier will also receive the vaccine to show leadership to staff and to show that the vaccine is safe.

More on The PennZone
  • Community, Conservation & Waterwise Inspiration Bloom on June 6
  • Industrial and systems engineers celebrate key leaders in the field at IISE Annual Conference
  • Cosanostra Miami Rises as the Best Latin Nightclub in Miami in Under Two Years From its Opening
  • CCHR Leader's 50-Year Fight for Psychiatric Drug Victims Gains National Momentum
  • Endless Mountain Music Festival Celebrates 21st Season with America250-Inspired Lineup

The vaccine will be distributed at the Skilled Nursing Facilities, through a partnership with CVS, on a schedule beginning December 29th, and at our Transitional Care Units starting January 4th. Our excellent healthcare staff, patients, and residents take priority and will receive the vaccines first.

A 90% or more adoption rate will significantly reduce outbreaks within each facility. The goal is 100%. It will take many resources to accomplish, but we're up to the task of keeping our family safe.

We also plan to implement CVS's VSafe app, a smartphone-based post-vaccination application that will allow those who have been vaccinated to sign up for monitoring post-vaccine statuses going forward. VSafe incorporates text messages and web surveys and relays information back to the CDC about how those who have been vaccinated are doing post-vaccine.

Visit our blog, where Dr. Paul Liguori at Whittier Rehabilitation Hospital Bradford, explains the vaccine process and how it works within your body: https://hubs.ly/H0CM8cN0.

For more information from the Centers for Disease Control, visit http://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html.

We look forward to the vaccine helping to protect the well-being of our employees, residents and patients.

Contact
Kathy Soderberg - Chief Compliance Officer
***@whittierhealth.com


Source: Whittier Health Network
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Creative Investment Research Analysis Finds Slower GDP Growth, Rising Inflation
  • TechHouse Earns Highly Selective Microsoft Support Badge
  • J&J Exterminating Celebrates 65th Anniversary and Unveils Strategic Vision at Annual Team Meeting
  • Tru by Hilton El Paso Airport Opens to Guests
  • Zenylitics Announces Leadership Transition to Continue Accelerated Growth
  • Wellness Technology Distributor Helping People Set Up Wellness Center Businesses
  • Christian Apocalyptic Thriller Explores Biblical Prophecy, Global Technology, & the Rise of the Ant
  • Turnstone Creative Expands Leadership Team with Addition of Marketing Manager
  • The Hidden Price Of Lost Property In UK Schools
  • Milton Collier, CEO & President of Freight Broker 911, Eliminates the #1 Barrier to Entry in Logistics: Announces 100% Free Freight Broker Training
  • FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP
  • AI Velocity Trading Launches Institutional-Grade Algorithmic Engine for Retail Investors
  • Calvetta Phair, CEO America's Workforce Solution, LLC Assessed "Awardable" for Department of War work in the CDAO's Tradewinds Solutions Marketplace
  • Speaker and Certified Coach Syrena N. Williams Debuts Powerful New Book on Healing, Identity, and Wholeness
  • Lord of the Rings, Doctor Who' Q&As, Local Sessions Highlight FAN EXPO Philadelphia Programming
  • Kryptokasinot.io Raises Concerns Over Proposed Cryptocurrency Restrictions in Finland's Gambling Reform
  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan
  • The Calida Group Announces Sale of Ely at Fort Apache for $57.5 Million
  • Tina Hasselbusch, co-founder and CEO of Turnstone Creative, Receives Circle of Excellence from Lehigh Valley Business
  • Summer Festivals in Gunma Prefecture: Song, Dance, and Vibrant Color – Get There Via Tobu Railway!

Popular on PennZone

  • People & Stories/Gente y Cuentos Welcomes Two New Trustees as Organization Enters 54th Year and Expands Community Reach
  • Resident Inspect Joins Property Meld Nexus Network with API Integration
  • Assymetrix Launches the Deepest Independent Prediction Market Data API
  • RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative
  • Expert E-Bike Safety Advocate Issues Urgent Warning Following Recent Southern California Fatalities
  • CCHR: 'Plant-Based' Psychedelics Push Masks Synthetic Drugs and Billion-Dollar Profits
  • "I'm Sicka Church Too: Give Me Kingdom!" Ignites a Powerful Call for Healing and Truth
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
  • Veikkaus Appoints New CFO as Finland's Gambling Monopoly Braces for Breakup
  • BTR: i2 Group Launches i2 Amplify, a Community Platform for Intelligence Professionals Worldwide

Similar on PennZone

  • Lineus Medical Completes Financial Restructuring with KMF Investments- Launching a New Era for SafeBreak
  • Neuro Recovery Institute Showcases Emerging Immersive Neuro-Rehabilitation Technology at Clinical Innovation Open House
  • Industrial and systems engineers celebrate key leaders in the field at IISE Annual Conference
  • CCHR Leader's 50-Year Fight for Psychiatric Drug Victims Gains National Momentum
  • Author Releases 7-Day Screen Time Reset for Families as Teachers Worldwide Report Children "Struggling to Grasp Basic Concepts"
  • Men's Health Month Begins with Record Proclamations, AP News Coverage, & National Momentum for Men's Health
  • Blueshirt Media Launches HIPAA-Compliant AI Call Answering for Addiction Treatment Centers
  • Wellness Technology Distributor Helping People Set Up Wellness Center Businesses
  • FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP
  • Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us